View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Chloe Orkin, MBChB, FRCP, MD, discusses exciting new HIV data reported at the virtual CROI 2021, including new findings on HIV PrEP, HIV and COVID-19, ART in pregnancy and the postpartum period, as well as on the comparative efficacy of various ARV regimens.
Presenter:
Chloe Orkin, MBChB, FRCP, MD
Professor of HIV
Queen Mary University of London
Consultant Physician
Lead for HIV Research
Barts Health NHS Trust
The Royal London Hospital
London, United Kingdom
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
Drs Monica Gandhi and Joseph Eron discuss next-line ART options for a heavily treatment-experienced patient with multiclass resistance .
Joseph J. Eron, Jr., MD
Monica Gandhi, MD, MPH
Physicians:
maximum of 0.5 AMA PRA Category 1 Credits™
Pharmacists:
0.5 contact hours (0.05 CEUs)
Released: April 19, 2021
Expired:
April 18, 2022
Clinical Care Options (CCO) commentary by Dr Zhao Yan on data presented at CROI 2021 on the impact of the COVID-19 pandemic on HIV treatment
Dr. Zhao Yan
Released: April 19, 2021
Download CCO slides reviewing data and guidelines on next-line ART for heavily-treatment experienced patients with HIV and multiclass drug resistance
Joseph J. Eron, Jr., MD
Monica Gandhi, MD, MPH
Released: April 19, 2021
Clinical Care Options (CCO) commentary by Nelly Mugo, MD, on new data from Kenya on STI incidence and on PrEP uptake from CROI 2021
Nelly Mugo, MBChB, MMed, MPH
Released: April 15, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.